Growth Metrics

Boston Scientific (BSX) Receivables (2016 - 2026)

Boston Scientific's Receivables history spans 18 years, with the latest figure at $3.2 billion for Q1 2026.

  • On a quarterly basis, Receivables rose 12.4% to $3.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.2 billion, a 12.4% increase, with the full-year FY2025 number at $3.1 billion, up 14.66% from a year prior.
  • Receivables hit $3.2 billion in Q1 2026 for Boston Scientific, up from $3.1 billion in the prior quarter.
  • Over the last five years, Receivables for BSX hit a ceiling of $3.2 billion in Q1 2026 and a floor of $1.9 billion in Q1 2022.
  • Historically, Receivables has averaged $2.4 billion across 5 years, with a median of $2.4 billion in 2024.
  • Biggest five-year swings in Receivables: increased 4.45% in 2022 and later rose 24.23% in 2024.
  • Tracing BSX's Receivables over 5 years: stood at $2.0 billion in 2022, then increased by 18.68% to $2.3 billion in 2023, then rose by 14.07% to $2.7 billion in 2024, then grew by 14.66% to $3.1 billion in 2025, then grew by 3.14% to $3.2 billion in 2026.
  • Business Quant data shows Receivables for BSX at $3.2 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.0 billion in Q3 2025.